Found 20 articles for: "tretinoin"
Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis
December 2025 | Volume 24 | Issue 12 | Original Article | 1168 | Copyright © December 2025
Background: Background: The increasing use of long-term, low-dose isotretinoin for acne has raised concerns about a potential association with inflammatory bowel disease (IBD), i...
Read MoreConsiderations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin
June 2025 | Volume 24 | Issue 6 | Editorials | 638 | Copyright © June 2025
Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors
June 2025 | Volume 24 | Issue 6 | Editorials | e38 | Copyright © June 2025
Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study
June 2025 | Volume 24 | Issue 6 | Features | 639 | Copyright © June 2025
Isotretinoin is used to treat severe nodulocystic acne. Cumulative doses of 120 to 150 mg/kg have been shown to limit adverse events while maximizing efficacy. Also proven safe, doses of 220 mg/k...
Read MoreConsensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process
June 2024 | Volume 23 | Issue 6 | Original Article | 429 | Copyright © June 2024
Oral isotretinoin remains a mainstay of treatment for severe, recalcitrant nodular acne. Novel formulations of isotretinoin have been developed over the past decade, including lidose isotretinoin...
Read MoreChallenges to Prescribing Isotretinoin to Patients at a Safety Net Hospital Dermatology Clinic
June 2024 | Volume 23 | Issue 6 | Case Reports | 477 | Copyright © June 2024
Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin
May 2023 | Volume 22 | Issue 5 | Original Article | 486 | Copyright © May 2023
Background: The incidence of keratinocyte carcinomas (KCs), comprising basal and squamous cell carcinomas, is rising in the United States. Chemoprevention is one modality by whic...
Read MoreSelf-Reported Long-Term Side Effects of Isotretinoin: A Case Series
April 2023 | Volume 22 | Issue 4 | Features | 423 | Copyright © April 2023
Citation: Ghadimi TR, Martinez MJ, Rieder EA. Self-reported long-term side effects of isotretinoin: A case series. J Drugs Dermatol. 2023;22(4):423-424. doi:10.36849/JDD.2303...
Read MoreTretinoin Review With Newer Formulations: Providing Effective and Tolerable Solutions in Clinical Practice
January 2023 | Volume 22 | Issue 1 | Original Article | 35 | Copyright © January 2023
Topical tretinoin has historically been limited by poor tolerability and molecular instability. Research advances have enhanced its efficacy and tolerability, along with reducing oxidation and photode...
Read MoreReview of Tretinoin-Benzoyl Peroxide in The Treatment of Acne Vulgaris
October 2022 | Volume 21 | Issue 10 | Original Article | 1098 | Copyright © October 2022
Background: Acne vulgaris has a multifactorial pathogenesis, and combination therapy is recommended in most patients. A tretinoin 0.1%/benzoyl peroxide 3% (Tret-BPO) cream which uses ...
Read MoreVehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream
August 2022 | Volume 21 | Issue 8 | Original Article | 875 | Copyright © August 2022
Background: Topical retinoids like tretinoin are a mainstay of acne treatment but associated cutaneous irritation and drying may lead to poor adherence. As vehicle optimization can im...
Read MoreOral Vitamin A for Acne Management: A Possible Substitute for Isotretinoin
June 2022 | Volume 21 | Issue 6 | Editorials | 683 | Copyright © June 2022
Background: Recent changes to the iPLEDGE platform left providers without the ability to prescribe isotretinoin to their patients. A potential substitute for isotretinoin could be ben...
Read MoreA Prospective, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy, Safety, and Patient Satisfaction of Tretinoin 0.05% Lotion for Chest Rejuvenation
June 2022 | Volume 21 | Issue 6 | Original Article | 645 | Copyright © June 2022
Background: There is increasing interest in non-invasive options for chest rejuvenation with minimal to no downtime. Topical retinoids have long been used to correct photoaging due to...
Read MoreSingle-Center, Prospective, Double-Blind, Evaluator-Blind, non-Randomized, Vehicle-Controlled Trial With a 1927 Nm Non-Ablative Fractionated Laser and Topical 0.05% Tretinoin Lotion for Facial Dyspigmentation and Photodamage
November 2021 | Volume 20 | Issue 11 | Original Article | 1174 | Copyright © November 2021
Background: Dyspigmentation and photodamage are common concerns in patients who seek aesthetic consultation. A number of treatment modalities have been utilized to address this issue....
Read MoreARTICLE: Advances in Oral Isotretinoin Therapy
May 2021 | Volume 20 | Issue 5 | Supplement Individual Articles | s5 | Copyright © May 2021
Since its approval in 1982, oral isotretinoin has revolutionized acne therapy. However, oral isotretinoin use has long been associated with challenges of variable bioavailability and food dependence. ...
Read MoreFULL SUPPLEMENT: Status Update: Isotretinoin
May 2021 | Volume 20 | Issue 5 | Department | 1s | Copyright © May 2021
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers
March 2021 | Volume 20 | Issue 3 | Original Article | 260 | Copyright © March 2021
Background: Minimally invasive alternative approaches to treat non-melanoma skin cancers remain limited and unproven.
Objective: We aim to assess the efficacy o...
Read MoreTolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris
March 2021 | Volume 20 | Issue 3 | Original Article | 295 | Copyright © March 2021
Acne vulgaris is the most common dermatological disorder worldwide, causing significant physical and psychological morbidity. Topical combination therapy has shown superior efficacy compared to monoth...
Read MoreA Method for Maintaining the Clinical Results of 4% Hydroquinone and 0.025% Tretinoin With a Cosmeceutical Formulation
April 2015 | Volume 14 | Issue 4 | Original Article | 386 | Copyright © April 2015
Facial dyspigmentation treatment is an unmet need in dermatology with increasing challenges due to the questionable safety of Read More
40 Years of Topical Tretinoin Use in Review
June 2013 | Volume 12 | Issue 6 | Original Article | 638 | Copyright © June 2013
Topical tretinoin has been approved for use in dermatology for 40 years and is currently approved for the treatm...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
